Deerfield Management
New York City, New Yorkdeerfield.com
Overview
Deerfield Management is a healthcare-focused investment firm that makes public and private investments in the healthcare, life science, medical device, diagnostic, digital health, and biotechnology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Boulevard Bio | Aug 2026 | Launch Financing | Lead |
| METiS Therapeutics | May 2026 | IPO | Co-investor |
| Ray Therapeutics | Apr 2026 | Series B | Co-investor |
| Neomorph | Apr 2026 | Series B | Lead |
| SHINE Technologies | Feb 2026 | Series E | Co-investor |
Key People
James Flynn
Managing Partner, Partner
Brian Chow
Managing Director
Michael Schelper
Operating Partner
Mussaad M. Al-Razouki
Operating Partner
Richard Rubino
Operating Partner
Steve Hochberg
Operating Partner
David Neustaedter
Venture Partner
Andrew ElBardissi
Partner
Avi Kometz
Partner
Brian M. Bizoza
Partner, Portfolio Oversight
Cameron Wheeler
Partner
Howie Furst
Partner
Jason Fuller
Partner
Konstantinos N. Aprilakis
Partner
Leslie Henshaw
Partner
Nicholas Bishop
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?